I. MacIntyre

Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease

D. Wheeler, J. Townend, T. Hiemstra, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation

D. Brindley, M. Benesch, T. McMullen, 2018, Cancers.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease

P. Mark, J. Traynor, J. Lees, 2020, Nephrology.

THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY AND INITIATIVE (FEIRI)- CLINICAL PHENOTYPES AND THEIR PREDICTORS BASED ON A COHORT OF ONE THOUSAND PATIENTS.

R. Cianci, P. Salice, J. Segura, 2020, Cardiovascular research.

CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS

S. Wimalawansa, M. Whitehead, L. Banks, 1988, The Lancet.

Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity.

J. Polak, Paul L Huang, F. Afzal, 2001, The American journal of pathology.